routes to this class of agent. Indeed, for some substrates the
affinity of 20 is superior to the natural product metabolite
(entries 5 and 7), suggesting adoption of unique architectures.
Given the ease of access to 20, we became interested to gauge
effectiveness as a molecular biology tool. Bulged structures
have been proposed as intermediates in DNA slippage
synthesis involving the extension of nucleotide repeats. Given
the possible involvement of the slippage process in the
progression of certain neurological disorders (e.g., CAG
repeats in Huntington’s disease10), a readily available reagent
capable of inducing slippage may have a number of uses.
Accordingly, 20 was subjected to a slippage assay, which
measures 32P TMP uptake for DNA slippage synthesis
dependent on primers/templates bearing simple sequence
repeats, catalyzed by the Klenow fragment of DNA poly-
merase I. The results (Table 2) confirm that 20 can
significantly promote slippage within the 5 h assay with >10-
fold induction at 30 µM.11
Table 1. Dissociation Constant (µM) of Spirocyclic Alkenes
20 for Selected Sequencesa
Table 2. Effect of 20 on DNA Slippage Synthesisa
32P incorporated (CPM)
stimulation
control
20 (10 µM)
20 (30 µM)
38 664
89 101
511 667
2.3
13.2
a DNA slippage synthesis was measured using the primer/template
oligomers of thymidylate (20-mer) and deoxyadenylate (30-mer) in a
reaction catalyzed by the Klenow fragment of DNA polymerase I.10 The
annealed mixture of T20/A30 (2 µM) in 50 mM Tris-HCl pH 7.5 was
supplied with 5 mM magnesium, 4 mM dithiothreitol, 1 mM dATP, 0.5
mM TTP, and 1.5 µCi [R- 32P]TTP before starting the synthesis by the
addition of enzyme. Test compound was present from the beginning of the
reaction. After incubation at 37° for 5 h. 32P-TMP incorporated into acid-
precipitable DNA products was determined, and data were reported relative
to control.11
a Fluorescence quenching studies conducted using a SPEX Fluoromax-2
at 4 °C in phosphate buffer (10 mmol, pH 7.0). Emission spectra of 20 and
21 were obtained in the range 400-600 nm upon excitation at 385 nm.
Emission reading at 490 nm was imported in binding calculation. Dissocia-
tion constant (kd) was derived from curve-fitting (Kaleidagraph).5
Prompted by the retro-aldol issue, we made a decision to
investigate the effects of eliminating the spiro alcohol group
altogether. Though the crystal structure of 2 suggests that
hydrogen bonding of this group contributes to secondary
structure, the wedge-shaped template should persist on the
basis of the spiro junction. Accordingly, elimination of the
alcohol from 9a to give alkene 17 was effected (Scheme 3).
Conversion to enone 18 was uneventful as expected, and
saponification followed by aminoglycosylation gave 19 and
its stereoisomer in good yield. At this point, diastereomer
resolution of stereoisomers at the spiro junction was possible,
the desired isomer subjected to deprotection to give NCSi-
gb mimic 20. To provide a convenient control substrate, the
spiro-inverted stereoisomer of 19 was subjected to identical
conditions to give substrate 21 (75%). A preliminary analysis
of binding against a panel of bulged oligonucleotides
confirmed that 20 is as effective as other aminoglycosylated
versions of 2 and in some cases is superior to NCSi-gb itself
(Table 1).9 The need for right-handed twist in order to satisfy
molecular recognition in the bulged environment is evident
by comparison to stereoisomer 21 (Table 1, entries 2-4).
The results confirm that a hydrogen bonding group is not
required at the spiro junction, greatly simplifying synthetic
In summary, a versatile and efficient route to mimics of
the natural product metabolite NCSi-gb has been developed.
The lead molecule, available in eight steps from a readily
available template, shows submicromolar and selective
binding to bulged DNA targets and induces slippage at
relevant concentrations, allowing for rational drug design to
address this key molecular biology target. Of potential
significance is the synthetic versatility of the vinyl group in
20, which will allow design and assembly of diverse libraries
for screening.12
Supporting Information Available: Experimental pro-
cedures and characterization data for all new compounds.
This material is available free of charge via the Internet at
OL0400591
(9) Xi, Z.; Jones, G. B.; Qabaja, G.; Wright, J. W.; Johnson, F. S.;
Goldberg, I. H. Org. Lett. 1999, 1, 1375-1377.
(10) Ruggiero, B. L.; Topal, M. D. J. Biol. Chem. 2004, 279, 23088-
23097.
(11) Kappen, L. S.; Xi, Z.; Jones, G. B.; Goldberg, I. H. Biochemistry
2003, 42, 2166-2173.
(12) We thank the NIH for financial support through Grants RO1GM57123
(to GBJ) and R01GM53793(to IHG).
(8) Attemps to isolate the intermediates in this cascade were unsuccessful.
74
Org. Lett., Vol. 7, No. 1, 2005